Kings Path Partners’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134K Buy
1,351
+299
+28% +$28.9K 0.04% 137
2026
Q2
$108K Sell
1,052
-500
-32% -$47.2K 0.03% 144
2026
Q1
$122K Sell
1,552
-99
-6% -$7.96K 0.04% 127
2025
Q4
$120K Sell
1,651
-16
-1% -$1.14K 0.04% 128
2025
Q3
$113K Sell
1,667
-34
-2% -$2.2K 0.04% 123
2025
Q2
$107K Buy
1,701
+53
+3% +$3.08K 0.04% 117
2025
Q1
$90.8K Sell
1,648
-1
-0.1% -$56 0.04% 119
2024
Q4
$91.4K Buy
1,649
+83
+5% +$4.87K 0.04% 143
2024
Q3
$95.7K Buy
1,566
+21
+1% +$1.26K 0.04% 143
2024
Q2
$91.5K Buy
+1,545
New +$89K 0.04% 133

Other funds holding EMXC

Kings Path Partners's EMXC Position: Q3 2026 in Review

Kings Path Partners increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 28% in Q3 2026, buying an estimated $28.9K and bringing the position to 1,351 shares worth $134K. The position accounts for 0.04% of the portfolio, ranked #137.

Kings Path Partners first reported a position in EMXC in Q2 2024 and has held it in 10 quarters since. 284 funds tracked by Wall St. Rank hold EMXC as of Q3 2026.

  • Kings Path Partners held 1,351 shares of iShares MSCI Emerging Markets ex China ETF worth $134K as of Q3 2026.
  • Kings Path Partners bought 299 iShares MSCI Emerging Markets ex China ETF shares in Q3 2026, an estimated $28.9K.
  • iShares MSCI Emerging Markets ex China ETF made up 0.04% of Kings Path Partners's portfolio in Q3 2026, its #137 holding.
  • Kings Path Partners first reported a position in iShares MSCI Emerging Markets ex China ETF in Q2 2024 and has held it in 10 quarters since.
  • 284 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.